Tirzepatide is a dual-agonist peptide that activates both GLP-1
and GIP receptors — two key
pathways involved in appetite regulation, insulin signalling, and energy balance. Unlike
single-agonist compounds such as Semaglutide, Tirzepatide targets two receptors
simultaneously, making it one of the most studied compounds in modern metabolic
research.
In clinical studies, Tirzepatide has demonstrated significant effects on body weight reduction and glycaemic control, outperforming many existing compounds in head-to-head trials. Its dual mechanism of action makes it a highly sought-after research tool for scientists investigating multi-pathway approaches to metabolic regulation and body
composition.
Peak Haven’s Tirzepatide20mg is manufactured to ≥99% purity (HPLC verified)
and shipped same-day via express delivery Australia-wide.
.
Are you over 18 years old?
This website requires you to be 18 years or older to enter our website and see the content.










